Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced autoimmunity.

Nancy J Olsen1

  • 1Department of Medicine Division of Rheumatology, T-3219 Medical Center North, Vanderbilt University, Nashville, TN 37232, USA. nancy.olsen@utsouthwestern.edu

Best Practice & Research. Clinical Rheumatology
|September 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective study of eating disorders and risk of rheumatoid arthritis.

Seminars in arthritis and rheumatism·2025
Same author

A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete Lupus.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Genetic relationships between systemic lupus erythematosus and a positive antinuclear antibody test in the absence of autoimmune disease.

Lupus science & medicine·2025
Same author

IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints.

The Journal of experimental medicine·2025
Same author

IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints.

bioRxiv : the preprint server for biology·2025
Same author

Integrating electronic health records and GWAS summary statistics to predict the progression of autoimmune diseases from preclinical stages.

Nature communications·2025
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Drug-induced autoimmune syndromes, including drug-induced lupus, are increasing in complexity and severity. New treatments for autoimmune diseases are driving these changes, making diagnosis more urgent and challenging.

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Drug-induced autoimmune syndromes are a known phenomenon, classically presenting as drug-induced lupus.
  • The landscape of these syndromes is evolving with the introduction of new pharmaceuticals and biologics for autoimmune disease treatment.

Purpose of the Study:

  • To explore the changing patterns and increasing complexity of drug-induced autoimmune syndromes.
  • To discuss proposed mechanisms underlying these syndromes and illustrate them with examples of implicated drugs.

Main Methods:

  • Review of existing literature on drug-induced autoimmune syndromes.
  • Analysis of case reports and limited controlled investigations.
  • Discussion of pathogenetic pathways based on implicated drugs.

Related Experiment Videos

Main Results:

  • The number and complexity of drug-induced autoimmune syndromes have increased.
  • Many syndromes are now associated with autoantibodies typically seen in idiopathic diseases.
  • Some drug-induced syndromes present with life-threatening complications.

Conclusions:

  • Recognition of drug-induced autoimmune syndromes is becoming more difficult yet more critical due to increased complexity and potential severity.
  • Understanding proposed pathogenetic mechanisms is essential for accurate diagnosis and management.